To include your compound in the COVID-19 Resource Center, submit it here.

EMA accepts MAA for Gentium's defibrotide

EMA accepted for review an MAA from Gentium S.p.A.

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE